Friday, May 20, 2011

FDA alert: SimplyThick can cause death

The following alert is from the FDA -do not feed SimplyThick to babies born before 37 weeks. It can cause necrotizing enterocolitis (NEC). NEC is very serious and can lead to death. Yuck! So, here's wishing that all babies are born on time, not too early, and get their nutrition safely while held in loving arms.

May all babies be born into loving hands...

 K. Michelle Doyle, CNM, NYS LM

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

SimplyThick: Public Health Notification - Risk of Life-Threatening Bowel Condition

AUDIENCE: Consumers, Pediatrics, Emergency medicine

ISSUE: FDA notified parents, caregivers and health care providers not to feed SimplyThick, a thickening agent for management of swallowing disorders, to infants born before 37 weeks. The product may cause necrotizing enterocolitis (NEC), a life-threatening condition characterized by inflammation and death of intestinal tissue.

BACKGROUND: FDA first learned of adverse events possibly linked to the product on May 13, 2011. To date, the agency is aware of 15 cases of NEC, including two deaths, involving premature infants who were fed SimplyThick for varying amounts of time. The product was mixed with mothers’ breast milk or infant formula. Illnesses have been reported from at least four different medical centers around the country. The illnesses of which FDA is aware involve premature infants. SimplyThick was added to the feeding regimen of those infants, who later developed NEC, to help with swallowing difficulties stemming from complications of premature birth.

The product is sold in packets of individual servings and in 64-ounce dispenser bottles. The product can be purchased from distributors and local pharmacies throughout the United States.

RECOMMENDATION: Health care providers should stop administering the product to premature infants. Parents and caregivers who have questions or concerns related to the use of the product and/or who have medical concerns should contact their health care provider. See the photographs at the link below for images of the product.

Read the MedWatch safety alert, including links to the Press Release and product photos, at:

Tell us how we are doing:[date]=05_20_2011_1800&cpp[type]=S

You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at
Follow MedWatch on Twitter twitter
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420

No comments:

Post a Comment